Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruo-Jing Li

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Molecular Pharmaceutics|April 7, 2009
Dual-targeting topotecan liposomes modified with tamoxifen and wheat germ agglutinin significantly improve drug transport across the blood-brain barrier and survival of brain tumor-bearing animalsJu Du, Wan-Liang Lu, Xue Ying, et al.
Molecular Pharmaceutics|November 11, 2010
Targeting therapy with mitosomal daunorubicin plus amlodipine has the potential to circumvent intrinsic resistant breast cancerYan Zhang, Ruo-Jing Li, Xue Ying, et al.
Cancer Letters|September 20, 2017
Pharmacological blockade of cholesterol trafficking by cepharanthine in endothelial cells suppresses angiogenesis and tumor growthJunfang Lyu, Eun Ju Yang, Sarah A Head, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 6, 2009
Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animalsXue Ying, He Wen, Wan-Liang Lu, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 15, 2015
Antifungal drug itraconazole targets VDAC1 to modulate the AMPK/mTOR signaling axis in endothelial cellsSarah A Head, Wei Shi, Liang Zhao, et al.
Circulation Research|December 28, 2017
Inositol Polyphosphate Multikinase Inhibits Angiogenesis via Inositol Pentakisphosphate-Induced HIF-1α DegradationChenglai Fu, Richa Tyagi, Alfred C Chin, et al.
International Journal of Biological Sciences|August 21, 2018
Astemizole Inhibits mTOR Signaling and Angiogenesis by Blocking Cholesterol TraffickingJunfang Lyu, Eun Ju Yang, Sarah A Head, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 12, 2022
FDA approval summary for lonafarnib (Zokinvy) for the treatment of Hutchinson-Gilford progeria syndrome and processing-deficient progeroid laminopathiesMari Suzuki, Linda J B Jeng, Solomon Chefo, et al.
Angewandte Chemie (International Ed. in English)|October 9, 2019
Discovery of a Potent GLUT Inhibitor from a Library of Rapafucins by Using 3D MicroarraysZufeng Guo, Zhiqiang Cheng, Jingxin Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 9, 2022
FDA Approval Summary: Belumosudil for Adult and Pediatric Patients 12 Years and Older with Chronic GvHD after Two or More Prior Lines of Systemic TherapyDonna Przepiorka, Robert Q Le, Alexei Ionan, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Molecular Pharmaceutics|April 7, 2009
Dual-targeting topotecan liposomes modified with tamoxifen and wheat germ agglutinin significantly improve drug transport across the blood-brain barrier and survival of brain tumor-bearing animalsJu Du, Wan-Liang Lu, Xue Ying, et al.
Molecular Pharmaceutics|November 11, 2010
Targeting therapy with mitosomal daunorubicin plus amlodipine has the potential to circumvent intrinsic resistant breast cancerYan Zhang, Ruo-Jing Li, Xue Ying, et al.
Cancer Letters|September 20, 2017
Pharmacological blockade of cholesterol trafficking by cepharanthine in endothelial cells suppresses angiogenesis and tumor growthJunfang Lyu, Eun Ju Yang, Sarah A Head, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 6, 2009
Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animalsXue Ying, He Wen, Wan-Liang Lu, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 15, 2015
Antifungal drug itraconazole targets VDAC1 to modulate the AMPK/mTOR signaling axis in endothelial cellsSarah A Head, Wei Shi, Liang Zhao, et al.
Circulation Research|December 28, 2017
Inositol Polyphosphate Multikinase Inhibits Angiogenesis via Inositol Pentakisphosphate-Induced HIF-1α DegradationChenglai Fu, Richa Tyagi, Alfred C Chin, et al.
International Journal of Biological Sciences|August 21, 2018
Astemizole Inhibits mTOR Signaling and Angiogenesis by Blocking Cholesterol TraffickingJunfang Lyu, Eun Ju Yang, Sarah A Head, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 12, 2022
FDA approval summary for lonafarnib (Zokinvy) for the treatment of Hutchinson-Gilford progeria syndrome and processing-deficient progeroid laminopathiesMari Suzuki, Linda J B Jeng, Solomon Chefo, et al.
Angewandte Chemie (International Ed. in English)|October 9, 2019
Discovery of a Potent GLUT Inhibitor from a Library of Rapafucins by Using 3D MicroarraysZufeng Guo, Zhiqiang Cheng, Jingxin Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 9, 2022
FDA Approval Summary: Belumosudil for Adult and Pediatric Patients 12 Years and Older with Chronic GvHD after Two or More Prior Lines of Systemic TherapyDonna Przepiorka, Robert Q Le, Alexei Ionan, et al.
Pageof 4